Application of a microfluidic chip-based 3D co-culture to test drug sensitivity for individualized treatment of lung cancer

Biomaterials

Volumn 34, Issue 16, 2013, Pages 4109-4117

  Xu, Zhiyun ^a   Gao, Yanghui ^a   Hao, Yuanyuan ^a   Li, Encheng ^a   Wang, Yan ^a   Zhang, Jianing ^a   Wang, Wenxin ^b   Gao, Zhancheng ^c   Wang, Qi ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

3D co culture; Chemotherapy; Drug sensitivity test; Individualized treatment; Lung cancer; Microfluidic chip

Indexed keywords

COCULTURE; DRUG SENSITIVITY; INDIVIDUALIZED TREATMENT; LUNG CANCER; MICROFLUIDIC CHIP;

BIOLOGICAL ORGANS; CELL CULTURE; CHEMOTHERAPY; DISEASES; FLUIDIC DEVICES; THREE DIMENSIONAL COMPUTER GRAPHICS; TISSUE;

DRUG DOSAGE;

ARTICLE; BIOASSAY; BIOCHIP; CANCER CELL CULTURE; CANCER TISSUE; CELL CULTURE; CONTROLLED STUDY; DRUG SENSITIVITY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG CANCER; MICROFLUIDIC ANALYSIS; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY ANALYSIS; STROMA CELL; STUDY DESIGN; SUPPLEMENTATION; TUMOR MICROENVIRONMENT;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL SHAPE; COCULTURE TECHNIQUES; DRUG SCREENING ASSAYS, ANTITUMOR; FIBROBLASTS; HUMANS; LUNG NEOPLASMS; MICROFLUIDIC ANALYTICAL TECHNIQUES; REPRODUCIBILITY OF RESULTS;

EID: 84874964737     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.02.045     Document Type: Article

References (33)

1. Devesa S.S., Bray F., Vizcaino A.P., Parkin D.M. International lung cancer trends by histologic type: male: female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005, 117:294-299.
2. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics. CA Cancer J Clin 2010, 60:277-300.
3. Califano R., Abidin A.Z., Peck R., Faivre-Finn C., Lorigan P. Management of small cell lung cancer: recent developments for optimal care. Drugs 2012, 72:471-490.
4. Gogvadze V., Orrenius S., Zhivotovsky B. Mitochondria as targets for cancer chemotherapy. Semin Cancer Biol 2009, 19:57-66.
5. Hatok J., Babusikova E., Matakova T., Mistuna D., Dobrota D., Racay P. In vitro assays for the evaluation of drug resistance in tumor cells. Clin Exp Med 2009, 9:1-7.
6. Ng C.P., Bonavida B. A new challenge for successful immunotherapy by tumors that are resistant to apoptosis: two complementary signals to overcome cross-resistance. Adv Cancer Res 2002, 85:145-174.
7. Wlodkowic D., Cooper J.M. Tumors on chips: oncology meets microfluidics. Curr Opin Chem Biol 2010, 14:556-567.
8. Huang C.P., Lu J., Seon H., Lee A.P., Flanagan L.A., Kim H.Y., et al. Engineering microscale cellular niches for three-dimensional multicellular co-cultures. Lab Chip 2009, 9:1740-1748.
9. Kalluri R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 2003, 3:422-433.
10. Nyberg P., Salo T., Kalluri R. Tumor microenvironment and angiogenesis. Front Biosci 2008, 13:6537-6553.
11. Kalluri R., Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006, 6:392-401.
12. Bhowmick N.A., Neilson E.G., Moses H.L. Stromal fibroblasts in cancer initiation and progression. Nature 2004, 432:332-337.
13. Liu S.Q., Yu J.P., Yu H.G., Lv P., Chen H.L. Activation of Akt and ERK signalling pathways induced by etoposide confer chemoresistance in gastric cancer cells. Dig Liver Dis 2006, 38:310-318.
14. Lin Z.Y., Chuang W.L., Chuang Y.H., Yu M.L., Hsieh M.Y., Wang L.Y., et al. Discordant influence of amphotericin B on epirubicin cytotoxicity in primary hepatic malignant cells collected by a new primary culture technique. J Gastroenterol Hepatol 2006, 21:398-405.
15. Kunz-Schughart L.A., Kreutz M., Kunechel R. Multicellular spheroids: a three-dimensional in vitro culture system to study tumour biology. Int J Exp Pathol 1998, 79:1-23.
16. Kobayashi H., Man S., Graham C.H., Kapitain S.J., Teicher B.A., Kerbel R.S. Acquired multicellular-mediated resistance to alkylating agents in cancer. Proc Natl Acad Sci U S A 1993, 90:3294-3298.
17. Mark D., Haeberle S., Roth G., von Stetten F., Zengerle R. Microfluidic lab-on-a-chip platforms: requirements, characteristics and applications. Chem Soc Rev 2010, 39:1153-1182.
18. West J., Becker M., Tombrink S., Manz A. Micro total analysis systems: latest achievements. Anal Chem 2008, 80:4403-4419.
19. Liu D., Wang L., Zhong R., Li B., Ye N., Liu X., et al. Parallel microfluidic networks for studying cellular response to chemical modulation. J Biotechnol 2007, 131:286-292.
20. Li X., Ling V., Li P.C. Same-single-cell analysis for the study of drug efflux modulation of multidrug resistant cells using a microfluidic chip. Anal Chem 2008, 80:4095-4102.
21. Zhao L., Wang Z., Fan S., Meng Q., Li B., Shao S., et al. Chemotherapy resistance research of lung cancer based on micro-fluidic chip system with flow medium. Biomed Microdevices 2010, 12:325-332.
22. Skommer J., Darzynkiewicz Z., Wlodkowic D. Cell death goes LIVE: technological advances in real-time tracking of cell death. Cell Cycle 2010, 9:2330-2341.
23. Li Jeon N., Baskaran H., Dertinger S.K., Whitesides G.M., Van de Water L., Toner M. Neutrophil chemotaxis in linear and complex gradients of interleukin-8 formed in a microfabricated device. Nat Biotechnol 2002, 20:826-830.
24. Duffy D.C., McDonald J.C., Schueller O.J., Whitesides G.M. Rapid prototyping of microfluidic systems in poly(dimethylsiloxane). Anal Chem 1998, 70:4974-4984.
25. Tilles A.W., Baskaran H., Roy P., Yarmush M.L., Toner M. Effects of oxygenation and flow on the viability and function of rat hepatocytes cocultured in a microchannel flat-plate bioreactor. Biotechnol Bioeng 2001, 73:379-389.
26. Dracopoulos A., Dixon D.G., Jones L.W., Sivak J.G., Bantseev V. In vitro assessment of medical device toxicity: interactions of benzalkonium chloride with silicone-containing and p-hema-containing hydrogel contact lens materials. Eye Contact Lens 2007, 33:26-37.
27. Blazka ME, Diaco M, Harbell JW, Raabe H, Sizemore A, Wilt N, et al. Epiocular TM human cell construct: tissue viability and histological changes following exposure to surfactants. Proceedings of the 5th world congress on alternatives and animal use in the life sciences; 2005.
28. Papa V., Leonardi A., Getuli C., Pacelli V., Russo P., Milazzo G. Effect of ofloxacin and netilmicin on human corneal and conjunctival cells in vitro. J Ocul Pharmacol Ther 2003, 19:535-545.
29. Urata Y., Nishimura Y., Hirase T., Yokoyama M. Sphingosine 1-phosphate induces alpha-smooth muscle actin expression in lung fibroblasts via Rho-kinase. Kobe J Med Sci 2005, 51:17-27.
30. Wu M.H., Huang S.B., Lee G.B. Microfluidic cell culture systems for drug research. Lab Chip 2010, 10:939-956.
31. Orimo A., Weinberg R.A. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 2006, 5:1597-1601.
32. Olumi A.F., Grossfeld G.D., Hayward S.W., Carroll P.R., Tlsty T.D., Cunha G.R. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999, 59:5002-5011.
33. Dong X., Guan J., English J.C., Flint J., Yee J., Evans K., et al. Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy. Clin Cancer Res 2010, 16:1442-1451.